111 related articles for article (PubMed ID: 30145226)
1. Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC.
Hsu SP; Lin PH; Chou CM; Lee WS
J Steroid Biochem Mol Biol; 2019 Jan; 185():163-171. PubMed ID: 30145226
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor-NFκB complex formation is required for progesterone-induced NFκB nuclear translocation and binding onto the p53 promoter.
Hsu SP; Yang HC; Kuo CT; Wen HC; Chen LC; Huo YN; Lee WS
Endocrinology; 2015 Jan; 156(1):291-300. PubMed ID: 25353185
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells.
Hsu SP; Lee WS
Mol Endocrinol; 2011 Mar; 25(3):421-32. PubMed ID: 21239614
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
Kuo CT; Lee WS
Cancer Lett; 2016 Aug; 378(2):104-10. PubMed ID: 27233474
[TBL] [Abstract][Full Text] [Related]
5. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract][Full Text] [Related]
6. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
7. Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II.
An BS; Choi JH; Choi KC; Leung PC
J Clin Endocrinol Metab; 2005 Feb; 90(2):1106-13. PubMed ID: 15562029
[TBL] [Abstract][Full Text] [Related]
8. Progesterone-induced migration inhibition in male rat aortic smooth muscle cells through the cSrc/AKT/ERK 2/p38 pathway-mediated up-regulation of p27.
Wang HC; Lee WS
Endocrinology; 2014 Apr; 155(4):1428-35. PubMed ID: 24479887
[TBL] [Abstract][Full Text] [Related]
9. Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway.
Hsu SP; Ho PY; Juan SH; Liang YC; Lee WS
Cell Mol Life Sci; 2008 Nov; 65(23):3839-50. PubMed ID: 18850315
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
Fettig LM; McGinn O; Finlay-Schultz J; LaBarbera DV; Nordeen SK; Sartorius CA
Oncogene; 2017 Nov; 36(44):6074-6084. PubMed ID: 28692043
[TBL] [Abstract][Full Text] [Related]
11. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
Shatnawi A; Tran T; Ratnam M
Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
[TBL] [Abstract][Full Text] [Related]
12. Progesterone induces RhoA Inactivation in male rat aortic smooth muscle cells through up-regulation of p27(kip1.).
Wang HC; Lee WS
Endocrinology; 2014 Nov; 155(11):4473-82. PubMed ID: 25137028
[TBL] [Abstract][Full Text] [Related]
13. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.
Lin SY; Lee WR; Su YF; Hsu SP; Lin HC; Ho PY; Hou TC; Chou YP; Kuo CT; Lee WS
Angiogenesis; 2012 Dec; 15(4):671-83. PubMed ID: 22843228
[TBL] [Abstract][Full Text] [Related]
14. Extra-Nuclear Signaling Pathway Involved in Progesterone-Induced Up-Regulations of p21cip1 and p27kip1 in Male Rat Aortic Smooth Muscle Cells.
Wang HC; Hsu SP; Lee WS
PLoS One; 2015; 10(5):e0125903. PubMed ID: 25932965
[TBL] [Abstract][Full Text] [Related]
15. Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.
Gizard F; Robillard R; Gervois P; Faucompré A; Révillion F; Peyrat JP; Hum WD; Staels B
FEBS Lett; 2005 Oct; 579(25):5535-41. PubMed ID: 16216245
[TBL] [Abstract][Full Text] [Related]
16. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
17. BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis.
Zhang N; Jiang T; Wang Y; Wang S; Hu L; Bu Y
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32093041
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of the progesterone receptor gene in granulosa cells: evidence that Sp1/Sp3 binding sites in the proximal promoter play a key role in luteinizing hormone inducibility.
Sriraman V; Sharma SC; Richards JS
Mol Endocrinol; 2003 Mar; 17(3):436-49. PubMed ID: 12554796
[TBL] [Abstract][Full Text] [Related]
19. Differential and interactive effects of ligand-bound progesterone receptor A and B isoforms on tyrosine hydroxylase promoter activity.
Jensik PJ; Arbogast LA
J Neuroendocrinol; 2011 Oct; 23(10):915-25. PubMed ID: 21815951
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
